Top compounds associated with response to LINC01420


Feature Type Standardized
Nominal ANOVA
mRNA 5-FU CTRPv2 pan-cancer AAC -0.06 0.08
mRNA BRD-K55473186 CTRPv2 pan-cancer AAC 0.082 0.09
mRNA SNX-2112 CTRPv2 pan-cancer AAC -0.055 0.09
mRNA Compound 1541A CTRPv2 pan-cancer AAC 0.068 0.09
mRNA AZD4547 CTRPv2 pan-cancer AAC 0.067 0.09
mRNA fulvestrant CTRPv2 pan-cancer AAC 0.13 0.09
mRNA dacarbazine CTRPv2 pan-cancer AAC -0.055 0.09
mRNA crizotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.059 0.09
mRNA Crizotinib CTRPv2 pan-cancer AAC -0.056 0.09
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.058 0.09
Download CSV